Massachusetts Financial Services CO Regeneron Pharmaceuticals, Inc. Transaction History

Massachusetts Financial Services CO

  • $320 Billion
  • Q3 2024

A detailed history of Massachusetts Financial Services CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 514,265 shares of REGN stock, worth $385 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
514,265
Previous 540,293 4.82%
Holding current value
$385 Million
Previous $568 Million 4.8%
% of portfolio
0.17%
Previous 0.18%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$1024.09 - $1201.76 $26.7 Million - $31.3 Million
-26,028 Reduced 4.82%
514,265 $541 Million
Q2 2024

Aug 09, 2024
BUY
$883.2 - $1071.19 $52.8 Million - $64 Million
59,769 Added 12.44%
540,293 $568 Million
Q1 2024

May 14, 2024
BUY
$902.69 - $993.35 $215 Million - $237 Million
238,174 Added 98.28%
480,524 $462 Million
Q4 2023

Feb 08, 2024
BUY
$775.18 - $881.7 $5.33 Million - $6.07 Million
6,879 Added 2.92%
242,350 $213 Million
Q3 2023

Nov 08, 2023
SELL
$692.45 - $844.37 $218 Million - $266 Million
-315,252 Reduced 57.24%
235,471 $194 Million
Q2 2023

Aug 09, 2023
SELL
$700.03 - $830.35 $562,124 - $666,771
-803 Reduced 0.15%
550,723 $396 Million
Q1 2023

May 10, 2023
BUY
$680.49 - $826.97 $2.22 Million - $2.69 Million
3,257 Added 0.59%
551,526 $453 Million
Q4 2022

Feb 13, 2023
BUY
$705.89 - $766.39 $247 Million - $268 Million
349,860 Added 176.33%
548,269 $396 Million
Q3 2022

Nov 09, 2022
BUY
$573.97 - $724.32 $114 Million - $144 Million
198,409 New
198,409 $137 Million
Q3 2021

Nov 10, 2021
SELL
$574.03 - $680.96 $1.52 Million - $1.8 Million
-2,650 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$472.8 - $558.54 $3.81 Million - $4.51 Million
-8,068 Reduced 75.28%
2,650 $1.48 Million
Q1 2021

May 13, 2021
SELL
$446.73 - $548.2 $48,693 - $59,753
-109 Reduced 1.01%
10,718 $5.07 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $516,564 - $656,618
-1,080 Reduced 9.07%
10,827 $5.23 Million
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $4.72 Million - $5.7 Million
8,663 Added 267.05%
11,907 $6.67 Million
Q2 2020

Aug 11, 2020
SELL
$493.32 - $643.92 $1.84 Million - $2.4 Million
-3,723 Reduced 53.44%
3,244 $2.02 Million
Q1 2020

May 14, 2020
SELL
$336.18 - $494.43 $257,850 - $379,227
-767 Reduced 9.92%
6,967 $3.4 Million
Q4 2019

Feb 13, 2020
SELL
$274.13 - $376.51 $4.53 Million - $6.22 Million
-16,512 Reduced 68.1%
7,734 $2.9 Million
Q3 2019

Nov 05, 2019
SELL
$273.46 - $318.39 $547,193 - $637,098
-2,001 Reduced 7.62%
24,246 $6.73 Million
Q2 2019

Aug 14, 2019
SELL
$299.6 - $414.82 $90.1 Million - $125 Million
-300,814 Reduced 91.97%
26,247 $8.22 Million
Q1 2019

May 13, 2019
BUY
$372.08 - $439.57 $45.5 Million - $53.8 Million
122,363 Added 59.78%
327,061 $134 Million
Q4 2018

Feb 08, 2019
BUY
$335.82 - $403.04 $9.89 Million - $11.9 Million
29,457 Added 16.81%
204,698 $76.5 Million
Q3 2018

Oct 25, 2018
SELL
$351.14 - $408.51 $636,265 - $740,220
-1,812 Reduced 1.02%
175,241 $70.8 Million
Q2 2018

Jul 30, 2018
SELL
$284.6 - $344.99 $38 Million - $46.1 Million
-133,671 Reduced 43.02%
177,053 $61.1 Million
Q1 2018

May 04, 2018
SELL
$315.82 - $393.78 $10.1 Million - $12.6 Million
-32,041 Reduced 9.35%
310,724 $107 Million
Q4 2017

Feb 14, 2018
SELL
$358.63 - $469.95 $57.1 Million - $74.9 Million
-159,333 Reduced 31.73%
342,765 $129 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $37.4 Million - $43.7 Million
86,705 Added 20.87%
502,098 $224 Million
Q2 2017

Aug 14, 2017
BUY
N/A
415,393
415,393 $204 Million

Others Institutions Holding REGN

# of Institutions
1,532
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email